Literature DB >> 1140259

Motion-modulated vestibular neurons: central versus peripheral effects of cholinergic blocking agents.

E B Kirsten, E P Schoener.   

Abstract

Mesh:

Substances:

Year:  1975        PMID: 1140259     DOI: 10.1007/bf01932466

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  8 in total

1.  Prevention and treatment of motion sickness.

Authors:  E M GLASER
Journal:  Proc R Soc Med       Date:  1959-11

2.  The Prevention and Treatment of Motion Sickness I. Seasickness.

Authors:  L N Gay; P E Carliner
Journal:  Science       Date:  1949-04-08       Impact factor: 47.728

3.  Angular and linear acceleration of a stereotaxically mounted cat.

Authors:  J H Licking; E B Kirsten; S M Ross
Journal:  J Appl Physiol       Date:  1970-09       Impact factor: 3.531

4.  Evaluation of sixteen anti-motion sickness drugs under controlled laboratory conditions.

Authors:  C D Wood; A Graybiel
Journal:  Aerosp Med       Date:  1968-12

5.  Physiological responses of frog vestibular fibers to horizontal angular rotation.

Authors:  W Precht; R Llinás; M Clarke
Journal:  Exp Brain Res       Date:  1971-10-25       Impact factor: 1.972

6.  The inhibitory vestibular efferent system and its relation to the cerebellum in the frog.

Authors:  R Llinás; W Precht
Journal:  Exp Brain Res       Date:  1969-08-19       Impact factor: 1.972

7.  Neurotransmitter synthesis in inner ear and lateral line sense organs.

Authors:  A Flock; D M Lam
Journal:  Nature       Date:  1974-05-10       Impact factor: 49.962

8.  Action of anticholinergic and related agents on single vestibular neurones.

Authors:  E B Kirsten; E P Schoener
Journal:  Neuropharmacology       Date:  1973-12       Impact factor: 5.250

  8 in total
  1 in total

1.  Characterizing the Access of Cholinergic Antagonists to Efferent Synapses in the Inner Ear.

Authors:  Choongheon Lee; Anjali K Sinha; Kenneth Henry; Anqi W Walbaum; Peter A Crooks; Joseph C Holt
Journal:  Front Neurosci       Date:  2021-12-14       Impact factor: 4.677

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.